Epidemiology of Hip And Knee Arthroplasty and Periprosthetic Joint Infection in Russian Federation

Background. Since there is no national arthroplasty registry in the Russian Federation, the exact number of arthroplasty operations performed is unknown. Aim of the study to evaluate the epidemiology of primary, revision hip and knee arthroplasty and periprosthetic joint infection in Russian Federation. Materials and Methods. The inquires were made to 85 subjects, 73 federal state budget institutions and 30 private hospitals. Results. Answers were received from 76 subjects of Russian Federation, 41 federal and 18 private hospitals. The studied indicators revealed to be pretty much heterogenic. The decrease of operations number from 20% to 40% in subjects of Russian Federation due to SARS-CoV-2 pandemic forced us to make no analysis for these 2020 indicators in Russian Federation generally. 147 061 primary hip and knee arthroplasties were performed in 2019 in Russian Federaion. 7 770 revison hip and knee arthroplasties were done. 6 606 cases of severe orthopaedic implant-assosiated infection were cured including 4 282 cases post hip and knee arthroplasties that constitutes 2,91 % from primary arthroplasties. Conclusions. The frequency of periprosthetic joint infection in Russian Federation correlates to the world data. High complexity for patients routing with implant-assosiated infection and strong demand for Federal Center of implant-assosiated orthopaedic infection are revealed.

Download Full-text

Reply to the Letter to the Editor: Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Hip and Knee Arthroplasty? A Systematic Review

Clinical Orthopaedics and Related Research ◽

10.1097/corr.0000000000002076 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Nicholas M. Desy ◽

Richard Ng ◽

Murray T. Wong

Keyword(s):

Systematic Review ◽

Knee Arthroplasty ◽

Periprosthetic Joint Infection ◽

Joint Infection ◽

Letter To The Editor ◽

Hip And Knee Arthroplasty

Download Full-text

Removal of Well-Fixed Hip and Knee Arthroplasty Components in the Setting of Periprosthetic Joint Infection

Periprosthetic Joint Infection: Practical Management Guide ◽

10.5005/jp/books/11779_41 ◽

2013 ◽

pp. 325-325

Author(s):

Gregory Deirmengian ◽

Erik Hansen

Keyword(s):

Knee Arthroplasty ◽

Periprosthetic Joint Infection ◽

Joint Infection ◽

Hip And Knee Arthroplasty

Download Full-text

Editor’s Spotlight/Take 5: Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Hip and Knee Arthroplasty? A Systematic Review

Clinical Orthopaedics and Related Research ◽

10.1097/corr.0000000000001883 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Seth S. Leopold

Keyword(s):

Systematic Review ◽

Knee Arthroplasty ◽

Periprosthetic Joint Infection ◽

Joint Infection ◽

Hip And Knee Arthroplasty

Download Full-text

The mildly decreased preoperative bilirubin level is a risk factor for periprosthetic joint infection after total hip and knee arthroplasty

Arthroplasty ◽

10.1186/s42836-021-00096-2 ◽

2021 ◽

Vol 3 (1) ◽

Author(s):

Jun Fu ◽

Xiyue Chen ◽

Ming Ni ◽

Xiang Li ◽

Libo Hao ◽

...

Keyword(s):

Risk Factor ◽

Bilirubin Level ◽

Knee Arthroplasty ◽

Periprosthetic Joint Infection ◽

Joint Infection ◽

Primary Arthroplasty ◽

Significant Difference ◽

Serologic Markers ◽

Hip And Knee Arthroplasty ◽

Laboratory Biomarkers

Abstract Background Many serologic markers are routinely tested prior to joint arthroplasty, but only few are commonly used to guide surgeons in determining patients most at risk of periprosthetic joint infection (PJI). The objective of this study was to investigate the association between preoperative bilirubin level and PJI after primary hip and knee arthroplasty. Methods A retrospective analysis was performed on patients undergoing revision hip and knee arthroplasty at our hospital from January 2016 to December 2019. Laboratory biomarkers were collected before the primary arthroplasty, as well as general patient information. The association between the above serologic markers and postoperative PJI was analyzed. Results A total of 72 patients (30 hips/42 knees) were analyzed, including 39 patients with PJI and 33 patients without PJI. Except for total bilirubin (TB) and direct bilirubin (DB), there was no significant difference between the remaining laboratory biomarkers. The preoperative TB and DB in the PJI group were 10.84 ± 0.61 μmol/L and 3.07 ± 0.19 μmol/L, respectively, which were lower than those in the non-PJI group (14.68 ± 0.75 μmol/L and 4.70 ± 0.39 μmol/L, P < 0.001). The area under the curve (AUC) of preoperative TB to predict PJI was 0.755 (P < 0.001, cutoff = 11.55 μmol/L, sensitivity = 66.67%, specificity = 75.76%). Meanwhile, the AUC of preoperative DB was 0.760 (P < 0.001, cutoff = 4.00 μmol/L, sensitivity = 84.62%, specificity = 54.45%). Conclusions The serum levels of TB and DB before the primary arthroplasty were lower in PJI patients than in non-PJI patients, and the preoperative values lower than 11.55 μmol/L and 4.00 μmol/L could be considered as a risk factor for postoperative PJI.

Download Full-text